Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$693M |
| 2 |
Constellation Brands
STZ
|
+$368M |
| 3 |
Tesla
TSLA
|
+$332M |
| 4 |
NVIDIA
NVDA
|
+$300M |
| 5 |
Booking.com
BKNG
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$821M |
| 2 |
Netflix
NFLX
|
+$777M |
| 3 |
AbbVie
ABBV
|
+$583M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$477M |
| 5 |
FedEx
FDX
|
+$456M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Consumer Discretionary | 17.72% |
| 3 | Financials | 13.25% |
| 4 | Healthcare | 11.94% |
| 5 | Communication Services | 11.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EQGP
501
DELISTED
EQGP Holdings, LP
EQGP
| $5.99M | 0.01% |
254,964
-514,304
| -67% | -$12.5M |
|
502
Antero Midstream
AM
$10.3B
| $5.9M | 0.01% |
312,841
-1,884
| -0.6% | -$33.5K |
|
|
ARCH
503
DELISTED
Arch Resources, Inc.
ARCH
| $5.58M | 0.01% |
71,213
-539,763
| -88% | -$46M |
|
|
TEP
504
DELISTED
Tallgrass Energy Partners, LP
TEP
| $5.56M | 0.01% |
128,342
-790
| -0.6% | -$33.9K |
|
505
General Dynamics
GD
$106B
| $5.49M | 0.01% |
29,468
-85,888
| -74% | -$17.6M |
|
|
PRSP
506
DELISTED
Perspecta Inc. Common Stock
PRSP
| $5.49M | 0.01% |
+267,322
| New | +$5.99M |
|
507
Starbucks
SBUX
$118B
| $5.26M | 0.01% |
107,612
-157,594
| -59% | -$8.94M |
|
508
Quanterix
QTRX
$164M
| $5.05M | ﹤0.01% |
351,831
+6,170
| +2% | +$107K |
|
509
State Street SPDR S&P Metals & Mining ETF
XME
$3.9B
| $4.32M | ﹤0.01% |
121,707
-3,724
| -3% | -$136K |
|
|
AMR
510
DELISTED
Alta Mesa Resources Inc
AMR
| $4.28M | ﹤0.01% |
627,822
-64,189
| -9% | -$464K |
|
511
Walt Disney
DIS
$172B
| $4.02M | ﹤0.01% |
+38,354
| New | +$3.92M |
|
|
SBT
512
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $3.81M | ﹤0.01% |
284,969
| – | – |
|
513
Inspire Medical Systems
INSP
$1.5B
| $3.19M | ﹤0.01% |
+89,306
| New | +$2.88M |
|
|
AUTL
514
Autolus Therapeutics
AUTL
$386M
| $3.17M | ﹤0.01% |
+118,243
| New | +$3.12M |
|
515
Ovid Therapeutics
OVID
$440M
| $3.08M | ﹤0.01% |
394,436
-256,220
| -39% | -$2.2M |
|
516
RenaissanceRe
RNR
$13.9B
| $2.85M | ﹤0.01% |
23,659
+5,621
| +31% | +$726K |
|
517
LyondellBasell Industries
LYB
$18.8B
| $2.82M | ﹤0.01% |
25,691
+4,012
| +19% | +$441K |
|
518
MakeMyTrip
MMYT
$5.1B
| $2.53M | ﹤0.01% |
70,027
+413
| +0.6% | +$14.8K |
|
519
Micron Technology
MU
$927B
| $2.32M | ﹤0.01% |
44,283
-10,177
| -19% | -$550K |
|
520
VF Corp
VFC
$7.16B
| $2.24M | ﹤0.01% |
+29,164
| New | +$2.2M |
|
521
HCA Healthcare
HCA
$92.8B
| $2.23M | ﹤0.01% |
+21,743
| New | +$2.2M |
|
522
Las Vegas Sands
LVS
$32B
| $2.19M | ﹤0.01% |
28,656
+20,076
| +234% | +$1.53M |
|
|
TPH
523
DELISTED
Tri Pointe Homes
TPH
| $2.17M | ﹤0.01% |
132,418
-3,622
| -3% | -$61.6K |
|
|
DFS
524
DELISTED
Discover Financial Services
DFS
| $2.14M | ﹤0.01% |
+30,436
| New | +$2.23M |
|
525
Copart
CPRT
$28.4B
| $2.09M | ﹤0.01% |
147,608
-5,460
| -4% | -$74K |
|
Similar funds
Jennison Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Jennison Associates held 740 positions worth $103B, up 2% from $101B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Jennison Associates withdrew a net $3.95B in Q2 2018, closing 87 positions and reducing 296 holdings. Its most notable exit was Great Plains Energy Incorporated, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jennison Associates opened a new position in AstraZeneca worth $677M.
- Jennison Associates's largest Q2 2018 buy was AstraZeneca: 9,637,084 shares worth $677M.
- Jennison Associates added most to Constellation Brands in Q2 2018, an estimated $368M increase.
- Jennison Associates's biggest Q2 2018 reduction was Charter Communications, cutting an estimated $821M.
- Jennison Associates fully exited Great Plains Energy Incorporated in Q2 2018, selling an estimated $152M.
- Jennison Associates's ten largest holdings make up 29% of its $103B portfolio in Q2 2018.
- Jennison Associates opened 89 new positions and closed 87 in Q2 2018.
- Jennison Associates's portfolio value rose 2% quarter-over-quarter to $103B.
Based on Jennison Associates's 13F filing for Q2 2018, filed 2 Aug 2018.